TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1654756

Group type: EXPERIMENTAL
Intervention: Lidocaine with sodium bicarbonate
Number of subjects: 100

Group type: COMPARATOR
Intervention: Lidocaine alone
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 16-gauge intravenous catheter
Number of subjects: 100

Group type: COMPARATOR
Intervention: 20-gauge intravenous catheter
Number of subjects: 100
Study: 6125184

Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Pindolol 5 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Metoprolol 50 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 30209607

Group type: EXPERIMENTAL
Intervention: Checklist group
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study: 29316176

Group type: EXPERIMENTAL
Intervention: Prandial insulin glulisine injection timing adjustment based on continuous glucose monitoring (arm B)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Pre-breakfast insulin glulisine injection (arm A)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Prandial insulin glulisine dosage (arm B)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Prandial insulin glulisine dosage (arm A)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Frequency of hypoglycaemic events (arm B)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Frequency of hypoglycaemic events (arm A)
Number of subjects: 121
Study: 26968957

Group type: EXPERIMENTAL
Intervention: CODES management intervention combining management, diagnostic, and evaluation tools for child survival.
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: CODES management intervention
Number of subjects: 16

Group type: COMPARATOR
Intervention: Comparison districts (control)
Number of subjects: 16
Study: 25296241

Group type: EXPERIMENTAL
Intervention: Intrapleural tPA/DNase therapy
Number of subjects: 107
Study: 23217889

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation using interferential current (IFC) applied to the abdomen (12 sessions, 20 min, 3 times per week, <40 mA, carrier frequency 4 kHz, varying beat frequency 80-150 Hz)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation using interferential current (IFC) applied to the abdomen
Number of subjects: 8
Study: 20197759

Group type: EXPERIMENTAL
Intervention: Alosetron
Number of subjects: 998

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 998
Study: 18001430

Group type: EXPERIMENTAL
Intervention: Ass's milk (AM)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Goat's milk (GM)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Food challenge with GM
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Food challenge with AM
Number of subjects: 28
Study: 15613075

Group type: EXPERIMENTAL
Intervention: Subgingival minocycline application plus scaling/root planing
Number of subjects: 15

Group type: COMPARATOR
Intervention: Scaling/root planing alone
Number of subjects: 15
Study: 12558470

Group type: EXPERIMENTAL
Intervention: Brinzolamide twice daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brinzolamide three times daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brinzolamide twice daily plus timolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brinzolamide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dorzolamide
Number of subjects: 0
Study: 10346769

Group type: EXPERIMENTAL
Intervention: Promethazine (25 mg for adults and 0.5/kg for children)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 8546884

Group type: EXPERIMENTAL
Intervention: Hyperhydrated subjects (0.1 g sodium chloride (NaCl)/kg body wt and 26 mL water/kg body wt)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Hypokinetic subjects (hypokinesia alone)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control subjects (normal ambulatory conditions)
Number of subjects: 30
Study: 2015394

Group type: EXPERIMENTAL
Intervention: 12.0 Gy total body irradiation
Number of subjects: 116

Group type: COMPARATOR
Intervention: 15.75 Gy total body irradiation
Number of subjects: 116
Study: 7280444

Group type: EXPERIMENTAL
Intervention: Target vaccine (containing serotypes 1, 3, 6, 7, 14, 18, 19, and 23)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Control vaccine (containing serotypes 2, 4, 5, 8, 9, 12, and 25)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Infants with two or fewer episodes before immunization
Number of subjects: 179
Study: 31365365

Group type: EXPERIMENTAL
Intervention: Primary Fascial Closure (PFC)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Bridged Repair
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Both groups (PFC and Bridged Repair)
Number of subjects: 129
Study: 30642368

Group type: EXPERIMENTAL
Intervention: Wasted infants
Number of subjects: 1119

Group type: EXPERIMENTAL
Intervention: Stunting
Number of subjects: 1119

Group type: EXPERIMENTAL
Intervention: Underweight
Number of subjects: 1119

Group type: EXPERIMENTAL
Intervention: Overall prevalence of malnutrition
Number of subjects: 1119
Study: 28137739

Group type: EXPERIMENTAL
Intervention: Etoposide 50 mg/m2 on days 1-5 and cisplatin 50 mg/m2 on days 1 and 8 every 4 weeks for two cycles (EP arm)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Paclitaxel 45 mg/m2 and carboplatin (AUC 2) on day 1 weekly (PC arm)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Etoposide/cisplatin (EP arm)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Paclitaxel/carboplatin (PC arm)
Number of subjects: 200
Study: 25584431

Group type: COMPARATOR
Intervention: Cylindrical polyvinyl chloride
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Cylindrical polyurethane
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Conical polyvinyl chloride
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Conical polyurethane
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 604
Study: 23954611

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 1280

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 1280
Study: 23227139

Group type: EXPERIMENTAL
Intervention: Active CPAP treatment
Number of subjects: 17

Group type: COMPARATOR
Intervention: Sham CPAP treatment
Number of subjects: 17
Study: 19577757

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Waiting List Control (WLC)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Non-depressed controls
Number of subjects: 48
Study: 17406837

Group type: EXPERIMENTAL
Intervention: Arginine (Arg; 20 g)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Amino acid mixture (AA)
Number of subjects: 8
Study: 15063433

Group type: EXPERIMENTAL
Intervention: TEE-guided strategy
Number of subjects: 833

Group type: COMPARATOR
Intervention: Conventional strategy
Number of subjects: 833
Study: 17130272

Group type: EXPERIMENTAL
Intervention: Complete anemia correction
Number of subjects: 603

Group type: COMPARATOR
Intervention: Partial anemia correction
Number of subjects: 603
Study: 10232626

Group type: EXPERIMENTAL
Intervention: MCT diet
Number of subjects: 12

Group type: COMPARATOR
Intervention: LCT diet
Number of subjects: 12
Study: 8752805

Group type: EXPERIMENTAL
Intervention: Ibutilide 0.005 mg/kg
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Ibutilide 0.010 mg/kg
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Ibutilide 0.015 mg/kg
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Ibutilide 0.025 mg/kg
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 1677283

Group type: EXPERIMENTAL
Intervention: Closed postoperative peritoneal lavage
Number of subjects: 83

Group type: COMPARATOR
Intervention: No closed postoperative peritoneal lavage (control)
Number of subjects: 83
Study: 6419419

Group type: EXPERIMENTAL
Intervention: Calcium valproate (Valontin, Parke‐Davis)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Valproic acid (Depakene capsules, Abbott)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sodium salt (Depakene syrup, Abbott)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Calcium valproate, Valproic acid, Sodium salt
Number of subjects: 12
Study: 30892438

Group type: EXPERIMENTAL
Intervention: Capacitive resistive monopolar radiofrequency (RF=448 kHz)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo radiofrequency
Number of subjects: 24
Study: 29089455

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 1251

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 1251

Group type: COMPARATOR
Intervention: None (control group)
Number of subjects: 1251
Study: 26527775

Group type: EXPERIMENTAL
Intervention: Paclitaxel plus trastuzumab and lapatinib (THL) for 16 weeks before surgery
Number of subjects: 305

Group type: COMPARATOR
Intervention: Paclitaxel plus trastuzumab (TH) for 16 weeks before surgery
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Paclitaxel plus lapatinib (TL)
Number of subjects: 305
Study: 25246664

Group type: EXPERIMENTAL
Intervention: Inhaled mannitol 400 mg twice a day for 52 weeks
Number of subjects: 461

Group type: COMPARATOR
Intervention: Low-dose mannitol control
Number of subjects: 461
Study: 21796421

Group type: EXPERIMENTAL
Intervention: 17 alpha-hydroxyprogesterone caproate (17‐OHPC) 250 mg intramuscularly
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo saline
Number of subjects: 112
Study: 19960973

Group type: EXPERIMENTAL
Intervention: Wenhua Juanbi Recipe (WJR) in addition to methotrexate (MTX, 7.5 mg per week), sulfasalazine (0.5 g, tid), and meloxicam (Mobic, 7.5 mg, bid)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group receiving only methotrexate (MTX, 7.5 mg per week), sulfasalazine (0.5 g, tid), and meloxicam (Mobic, 7.5 mg, bid)
Number of subjects: 100
Study: 17579182

Group type: EXPERIMENTAL
Intervention: DNAemia cut-off of 10,000 DNA copies/mL
Number of subjects: 178

Group type: COMPARATOR
Intervention: Positive antigenemia
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: DNAemia cut-off
Number of subjects: 178
Study: 15077102

Group type: EXPERIMENTAL
Intervention: Enalapril (2.5 mg bid increased to 10 mg bid)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 12098166

Group type: EXPERIMENTAL
Intervention: Single cycles of sinewave frequencies between 1 and 35kHz delivered at 50Hz
Number of subjects: 16
Study: 9414326

Group type: COMPARATOR
Intervention: Weekly contact with a nurse
Number of subjects: 2422

Group type: EXPERIMENTAL
Intervention: Daily contact with a nurse
Number of subjects: 2422

Group type: EXPERIMENTAL
Intervention: Daily contact with a nurse and home monitoring of uterine activity
Number of subjects: 2422
Study: 7522018

Group type: EXPERIMENTAL
Intervention: Aprotinin (2 x 10(6) KIU loading dose followed by an infusion of 0.5 x 10(6) KIU/h for 4 h)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Aprotinin
Number of subjects: 60
Study: 29788227

Group type: EXPERIMENTAL
Intervention: Creating a smoke-free home (SFH)
Number of subjects: 941

Group type: COMPARATOR
Intervention: No smoke-free home (control)
Number of subjects: 941
Study: 28453721

Group type: EXPERIMENTAL
Intervention: lipoprotein apheresis
Number of subjects: 20

Group type: COMPARATOR
Intervention: sham
Number of subjects: 20
Study: 26320081

Group type: EXPERIMENTAL
Intervention: Integrated intensive smoking plus alcohol intervention using cognitive behavioral therapy (CBT)
Number of subjects: 645

Group type: EXPERIMENTAL
Intervention: Intensive smoking intervention using CBT
Number of subjects: 645

Group type: COMPARATOR
Intervention: Usual care (brief smoking cessation and brief alcohol counseling)
Number of subjects: 645
Study: 22818224

Group type: EXPERIMENTAL
Intervention: Intravenous omeprazole 0.5mg/kg every 12 hours
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Intravenous omeprazole 1mg/kg every 12 hours
Number of subjects: 37
Study: 22011457

Group type: EXPERIMENTAL
Intervention: Salmon consumption (2 portions per week)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (habitual diet)
Number of subjects: 0
Study: 19880686

Group type: EXPERIMENTAL
Intervention: Armodafinil, 150 mg
Number of subjects: 254

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 254
Study: 16540816

Group type: EXPERIMENTAL
Intervention: Family-focused cognitive behavioral therapy (CBT; the Building Confidence Program)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Child-focused cognitive behavioral therapy (CBT) with minimal family involvement
Number of subjects: 40
Study: 14533657

Group type: EXPERIMENTAL
Intervention: Azelastine nasal spray (2 sprays per nostril twice daily)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Azelastine nasal spray
Number of subjects: 78
Study: 10674754

Group type: EXPERIMENTAL
Intervention: Weight-drop contusion model
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Electrophysiological recordings
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: High-resolution magnetic resonance imaging (MRI)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Histological analysis
Number of subjects: 27

Group type: COMPARATOR
Intervention: Comparative analysis with human SCI data
Number of subjects: 27
Study: 9311405

Group type: EXPERIMENTAL
Intervention: Intravenous morphine (50 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intraperitoneal morphine (50 mg)
Number of subjects: 30
Study: 8322146

Group type: EXPERIMENTAL
Intervention: Choledochoduodenostomy (CD)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Choledochojejunostomy (CJ)
Number of subjects: 130
Study: 3568062

Group type: EXPERIMENTAL
Intervention: Cefotaxime (2 gm IV)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (no cefotaxime)
Number of subjects: 48
Study: 30340425

Group type: EXPERIMENTAL
Intervention: 2 g of leucine (LEU)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: mixed meal (protein 27.5 g, including 2.15 g of leucine) only (MEAL)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 2 g of leucine immediately after a mixed meal (MEAL-LEU)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 2 g of leucine 180 min after a mixed meal (MEAL-LEU180)
Number of subjects: 10
Study: 27541690

Group type: EXPERIMENTAL
Intervention: Dietary LCω3PUFA intake of at least 500 mg/d
Number of subjects: 3482

Group type: EXPERIMENTAL
Intervention: Yearly updated LCω3PUFA intake
Number of subjects: 3482

Group type: COMPARATOR
Intervention: Not meeting the LCω3PUFA recommendation (<500 mg/d)
Number of subjects: 3482
Study: 24965132

Group type: EXPERIMENTAL
Intervention: Cancellous screws
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Sliding hip screws
Number of subjects: 1000
Study: 22339104

Group type: EXPERIMENTAL
Intervention: Abdominal breathing (slow respiration with inspiratory pause)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Abdominal breathing (normal respiration)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (normal respiration)
Number of subjects: 20
Study: 20361335

Group type: EXPERIMENTAL
Intervention: Presence of lateral node metastasis
Number of subjects: 1046

Group type: EXPERIMENTAL
Intervention: Risk factors for lateral node metastasis
Number of subjects: 1046
Study: 17568402

Group type: EXPERIMENTAL
Intervention: Buprenorphine with ultra-low-dose naloxone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Buprenorphine alone
Number of subjects: 0
Study: 15954968

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 60
Study: 12027854

Group type: EXPERIMENTAL
Intervention: Thoracic epidural analgesia with a bupivacaine/morphine infusion (EPI-group, n=6)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Continuous i.v. infusion of morphine (MO-group, n=8)
Number of subjects: 14
Study: 10624296

Group type: EXPERIMENTAL
Intervention: Bupivacaine with adrenaline
Number of subjects: 24

Group type: COMPARATOR
Intervention: Normal saline solution (Control)
Number of subjects: 24
Study: 7795987

Group type: EXPERIMENTAL
Intervention: Synchronous two-team approach (group 2, n = 13)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Conventional Lewis-Tanner operation (group 1, n = 14)
Number of subjects: 27
Study: 1780340

Group type: EXPERIMENTAL
Intervention: Naltrexone 50 mg
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 7021612

Group type: EXPERIMENTAL
Intervention: Prednisone (80 mg by mouth for 3 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30652171

Group type: EXPERIMENTAL
Intervention: Extrinsic wheat fibre (VITACEL® wheat fibre), ∼20 grams of additional fibre per day, for 10 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control food products with conventional levels of fibre
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extrinsic wheat fibre (VITACEL® wheat fibre)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 0
Study: 30156578

Group type: EXPERIMENTAL
Intervention: Smoking cessation intervention
Number of subjects: 1357
Study: 27895044

Group type: EXPERIMENTAL
Intervention: GNAS c.393C>T TT genotype
Number of subjects: 1145

Group type: EXPERIMENTAL
Intervention: GNAS c.2273C>T TT genotype
Number of subjects: 1145

Group type: EXPERIMENTAL
Intervention: GNAS c.393C>T TT genotype (either SNP)
Number of subjects: 1145

Group type: COMPARATOR
Intervention: GNAS c.393C>T
Number of subjects: 1145
Study: 24519200

Group type: EXPERIMENTAL
Intervention: Oxybutynin 10 mg daily
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 22967224

Group type: EXPERIMENTAL
Intervention: Phone counseling (n=462)
Number of subjects: 1386

Group type: EXPERIMENTAL
Intervention: Internet counseling (n=464)
Number of subjects: 1386

Group type: COMPARATOR
Intervention: Self-help (control group)
Number of subjects: 1386

Group type: EXPERIMENTAL
Intervention: Phone counseling
Number of subjects: 1386

Group type: EXPERIMENTAL
Intervention: Internet counseling
Number of subjects: 1386
Study: 20947066

Group type: EXPERIMENTAL
Intervention: MDMA (1.5 mg/kg)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: MDMA (.75 mg/kg)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: METH (20 mg)
Number of subjects: 21
Study: 17535171

Group type: EXPERIMENTAL
Intervention: Group Triple P - Positive Parenting Program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 0
Study: 16208088

Group type: EXPERIMENTAL
Intervention: Web-based diabetic education (3 months, weekly SMS recommendations)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 34
Study: 12352293

Group type: EXPERIMENTAL
Intervention: Omeprazole (40 mg/d orally twice daily) for 14 days
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Omeprazole in GERD-positive patients
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo in GERD-positive patients
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Omeprazole in GERD-negative patients
Number of subjects: 42
Study: 9925239

Group type: EXPERIMENTAL
Intervention: ASA (25 mg twice daily)
Number of subjects: 6602

Group type: EXPERIMENTAL
Intervention: DP (200 mg twice daily)
Number of subjects: 6602

Group type: EXPERIMENTAL
Intervention: Combination of ASA and DP
Number of subjects: 6602

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6602
Study: 7768079

Group type: EXPERIMENTAL
Intervention: Methamphetamine (30 mg) and ethanol (1 gm/kg) combination
Number of subjects: 8

Group type: COMPARATOR
Intervention: Methamphetamine (30 mg) alone
Number of subjects: 8

Group type: COMPARATOR
Intervention: Ethanol (1 gm/kg) alone
Number of subjects: 8
Study: 2292255

Group type: EXPERIMENTAL
Intervention: Multivariate regression method
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Model-based method
Number of subjects: 90

Group type: COMPARATOR
Intervention: Quasi-orthogonal method
Number of subjects: 90
Study: 7015792

Group type: EXPERIMENTAL
Intervention: Haloperidol (10 to 60 mg daily)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Thioridazine (100 to 600 mg daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 29337008

Group type: EXPERIMENTAL
Intervention: Ice-pack application for 10 minutes
Number of subjects: 69

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 69
Study: 25994474

Group type: EXPERIMENTAL
Intervention: Patient-Specific Instrumentation (PSI)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Computer-Assisted Surgery (CAS)
Number of subjects: 80
Study: 25618965

Group type: EXPERIMENTAL
Intervention: Electric acupuncture
Number of subjects: 340

Group type: COMPARATOR
Intervention: Control (routine therapy alone)
Number of subjects: 340
Study: 23072088

Group type: EXPERIMENTAL
Intervention: Acupuncture at special acupoints (Chongyang, Fenglong, Zusanli, Liangqiu)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Acupuncture at non-specific acupoints (Tiaokou, Yinshi, Futu, Dubi)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Non-acupoints treatment
Number of subjects: 116
Study: 20715733

Group type: EXPERIMENTAL
Intervention: Warm group (37 degrees C)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Cold group (21 degrees C)
Number of subjects: 24
Study: 17768151

Group type: EXPERIMENTAL
Intervention: Government legislation, restrictions on advertising, and educational programmes
Number of subjects: 0
Study: 15885845

Group type: EXPERIMENTAL
Intervention: Diet group (D)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Diet and exercise group (DE)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 77
Study: 12515574

Group type: EXPERIMENTAL
Intervention: Basiliximab (20mg intravenous bolus on day 0 and day 4)
Number of subjects: 340

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 340
Study: 10713317

Group type: EXPERIMENTAL
Intervention: Warfarin dosage scheme based on a transition factor of 2.3 times the phenprocoumon dose; no specific dosage or duration mentioned.
Number of subjects: 104
Study: 9126697

Group type: EXPERIMENTAL
Intervention: Meropenem
Number of subjects: 515

Group type: COMPARATOR
Intervention: Clindamycin plus Gentamicin
Number of subjects: 515
Study: 1567347

Group type: EXPERIMENTAL
Intervention: Multicomponent psychological treatment (relaxation, thermal biofeedback, and cognitive therapy)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Attention-placebo control (pseudo-meditation and EEG alpha suppression biofeedback)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Symptom-monitoring control
Number of subjects: 40